Otros idiomas Neurotech International Limited

Acciones

NTI

AU000000NTI9

Mercado cerrado - Australian S.E. Otros sitios de cotización 07:38:57 28/06/2024			Varia. Cinco días.	Varia. 1 de enero.
0,07 ^AUD	-2,78 %		+4,48 %	+1,45 %

06/06	La relajación de las preocupaciones sobre la subida de tipos apuntala las acciones australianas	MT
06/06	El ensayo ampliado del fármaco NTI164 de Neurotech arroja nuevas mejoras; las acciones suben casi un 11	MT

Otros idiomas

Desbloquee todas las noticias: ¡Sea el primero en enterarse y reaccione antes que los mercados!

Inscripción 100% Gratuita

Neurotech International Establishes Advisory Group for Pediatric Medication; Shares Fall 3%	28/06
Easing Rate Hike Concerns Shore Up Australian Shares	06/06
Neurotech's Extended NTI164 Drug Trial Yields Further Improvements; Shares Surge Nearly 11%	06/06
Neurotech's Phase II/III NTIASD2 Clinical Trial for Children with Autism Meets Primary Endpoint	17/04
Neurotech International Completes AU$10 Million Capital Raise	17/04
Rice Biotech Launch Pad startup Motif Neurotech announces peer-reviewed publication on wireless cortical stimulator for precise neuromodulation	15/04
Neurotech International Concludes Phase II/III NTIASD2 Trial for Children with Autism	10/04
Neurotech International Limited Reports Earnings Results for the Half Year Ended December 31, 2023	26/02
Neurotech Receives Human Research Ethics Committee Approval to Extend Autism Trial	13/02
Neurotech's ASD Drug Trials Exceed 90 Weeks	07/02
Neurotech International Secures Approval to Advance Cerebral Palsy Trial; Shares Rise 6%	29/01
Neurotech International Completes Enrolment for Phase 2/3 Autism Spectrum Trial	19/12
Neurotech International Secures Ethics Approval for Use of Autism Spectrum Medication in Adults	04/12
Neurotech International Secures AU$3 Million R&D Tax Rebate for Fiscal Year 2023	14/11
Retinitis Pigmentosa Pipeline, Clinical Trials Studies, Emerging Drugs, Mergers and Acquisition, Licensing, Agreements & Collaborations, and Latest News 2023 (Updated)	13/11
Butterfly Network Announces 5-Year Co-Development Agreement with Forest Neurotech for Next-generation Brain Computer Interfaces Using Ultrasound-on-Chip Technology	25/10/23
Neurotech International Completes Enrollment for Rett Syndrome Trial	26/09/23
Alex Gorsky Joins Neurotech's Board as Lead Director	14/09/23
Neurotech International Completes Treatment for Last Patient in Phase I/II PANDAS/PANS Clinical Trial	31/08/23
Neurotech International Limited Reports Earnings Results for the Full Year Ended June 30, 2023	30/08/23

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Neurotech International Limited

Acciones

NTI

AU000000NTI9

Otros idiomas

Filtros